P. Brochard
Université Bordeaux Segalen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by P. Brochard.
Occupational and Environmental Medicine | 2006
M. Goldberg; E. Imbernon; P. Rolland; A. Gilg Soit Ilg; M Savès; A. De Quillacq; C. Frenay; Soizick Chamming's; P Arveux; C Boutin; Guy Launoy; J.-C. Pairon; Philippe Astoul; Françoise Galateau-Sallé; P. Brochard
Objectives: The French National Mesothelioma Surveillance Program (NMSP) was established in 1998 by the National Institute for Health Surveillance (InVS). Its objectives are to estimate the trends in mesothelioma incidence and the proportion attributable to occupational asbestos exposure, to help improve its pathology diagnosis, to assess its compensation as an occupational disease, and to contribute to research. Methods: The NMSP records incident pleural tumours in 21 French districts that cover a population of approximately 16 million people (a quarter of the French population). A standardised procedure of pathological and clinical diagnosis ascertainment is used. Lifetime exposure to asbestos and to other factors (man made mineral fibres, ionising radiation, SV40 virus) is reconstructed, and a case-control study was also conducted. The proportion of mesothelioma compensated as an occupational disease was assessed. Results: Depending on the hypothesis, the estimated number of incident cases in 1998 ranged from 660 to 761 (women: 127 to 146; men: 533 to 615). Among men, the industries with the highest risks of mesothelioma are construction and ship repair, asbestos industry, and manufacture of metal construction materials; the occupations at highest risk are plumbers, pipe-fitters, and sheet-metal workers. The attributable risk fraction for occupational asbestos exposure in men was 83.2% (95% CI 76.8 to 89.6). The initial pathologist’s diagnosis was confirmed in 67% of cases, ruled out in 13%, and left uncertain in the others; for half of the latter, the clinical findings supported a mesothelioma diagnosis. In all, 62% applied for designation of an occupational disease, and 91% of these were receiving workers’ compensation. Conclusions: The NMSP is a large scale epidemiological surveillance system with several original aspects, providing important information to improve the knowledge of malignant pleural mesothelioma, such as monitoring the evolution of its incidence, of high risk occupations and economic sectors, and improving pathology techniques.
Annales De Pathologie | 2014
Françoise Galateau-Sallé; A. Gilg Soit Ilg; N. Le Stang; P. Brochard; Jean-Claude Pairon; Philippe Astoul; C. Frenay; G. Blaizot; S. Chamming's; S. Ducamp; T. Rousvoal; A. De Quillacq; V. Abonnet; Issam Abd-Alsamad; Hugues Begueret; Elizabeth Brambilla; Frédérique Capron; Marie-Christine Copin; Claire Danel; A.Y. de Lajartre; A. Foulet-Roge; L. Garbe; Odile Groussard; S. Giusiano; Véronique Hofman; Sylvie Lantuejoul; J.M. Piquenot; Isabelle Rouquette; Christine Sagan; Françoise Thivolet-Béjui
Mesothelioma is a rare disease less than 0.3% of cancers in France, very aggressive and resistant to the majority of conventional therapies. Asbestos exposure is nearly the only recognized cause of mesothelioma in men observed in 80% of case. In 1990, the projections based on mortality predicted a raise of incidence in mesothelioma for the next three decades. Nowadays, the diagnosis of this cancer is based on pathology, but the histological presentation frequently heterogeneous, is responsible for numerous pitfalls and major problems of early detection toward effective therapy. Facing such a diagnostic, epidemiological and medico-legal context, a national and international multidisciplinary network has been progressively set up in order to answer to epidemiological survey, translational or academic research questions. Moreover, in response to the action of the French Cancer Program (action 23.1) a network of pathologists was organized for expert pathological second opinion using a standardized procedure of certification for mesothelioma diagnosis. We describe the network organization and show the results during this last 15years period of time from 1998-2013. These results show the major impact on patients management, and confirm the interest of this second opinion to provide accuracy of epidemiological data, quality of medico-legal acknowledgement and accuracy of clinical diagnostic for the benefit of patients. We also show the impact of these collaborative efforts for creating a high quality clinicobiological, epidemiological and therapeutic data collection for improvement of the knowledge of this dramatic disease.
Revue des Maladies Respiratoires Actualités | 2010
P. Brochard; M. Vincent; Jean-Claude Pairon; Pascal Dumortier; P. De Vuyst; T. Gille
Resume L’inhalation de particules minerales peut provoquer une grande variete d’affections pulmonaires. L’identification d’une retention de ces particules par l’analyse mineralogique, suivant des recommandations techniques rappelees dans ce texte, peut etre un outil diagnostique indispensable et permettre l’ouverture de droits au travailleur expose. Parce qu’elles peuvent etre causees par des expositions cumulees relativement faibles, les atteintes pleurales benignes et le mesotheliome dominent la pathologie asbestosique, tandis que le nombre de cancers broncho-pulmonaires lies a l’amiante semble sous-estime et que l’asbestose est devenue rare dans les pays developpes, tout comme les autres pneumoconioses.
American Journal of Industrial Medicine | 2012
C. Gramond; Patrick Rolland; Aude Lacourt; S. Ducamp; Soizick Chamming's; Yvon Creau; M. Hery; Jacques Laureillard; Brahim Mohammed-Brahim; Ewa Orlowski; Christophe Paris; Jean-Claude Pairon; M. Goldberg; P. Brochard
American Journal of Industrial Medicine | 2013
Soizick Chamming's; Bénédicte Clin; P. Brochard; Philippe Astoul; S. Ducamp; Fançoise Galateau‐Salle; Annabelle Gilg Soit Ilg; M. Goldberg; C. Gramond; Ellen Imbernon; Patrick Rolland; J.-C. Pairon
Lung Cancer | 2006
P. Rolland; S. Ducamp; C. Gramond; Françoise Galateau-Sallé; J.-C. Pairon; Philippe Astoul; Soizick Chamming's; A. Gilg Soit Ilg; E. Imbernon; M. Goldberg; P. Brochard
Safety Science | 2014
Fanny Bourrée; Louis Rachid Salmi; Alain Garrigou; Sandrine Domecq; P. Brochard; Philippe Michel
/data/revues/03987620/0050SUP4/1S56/ | 2008
A Gilg Soit Ilg; Guy Launoy; F Galateau; Philippe Astoul; P. Brochard; J.-C. Pairon; E. Imbernon; M. Goldberg
Occupational and Environmental Medicine | 2007
A. G. Kraut; K. M. Venables; S. Allender; R. McNamee; M. Carder; Y. Chen; R. Agius; A.G.S. Ilg; E. Imbernon; P. Rolland; S. Ducamp; A. De Quillacq; C. Frenay; Soizick Chamming's; Guy Launoy; J.-C. Pairon; Philippe Astoul; Françoise Galateau-Sallé; P. Brochard; M. Goldberg; B. Geoffroy-Perez; S. Julliard; A. Fouquet; S. H. Lo; J. D. Wang; C. S. Liau; A. Carosi; N. Lightfoot; K. Alkema; T. R. Driscoll
Lung Cancer | 2006
Françoise Galateau-Sallé; P. Vergani; Philippe Astoul; P. Rolland; J.-C. Pairon; P. Brochard; M. Matrat; V. Abonnet; E. Imbernon; A. Gilg Soit Ilg; M. Goldberg; Guy Launoy